Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. NATIONAL STOCK EXCHANGE OF AUSTRALIA LIMITED
  5. VGI Health Technology Limited
  6. Summary
    VTL   AU0000152597

VGI HEALTH TECHNOLOGY LIMITED

(VTL)
 SummaryChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote National Stock Exchange O…
07/19/2021 09/15/2021 09/23/2021 09/28/2021 10/04/2021 Date
0.15 0.19 0.22 0.25 0.25 Last
19386 20000 22683 4750 2317 Volume
0.00% +26.67% +15.79% +13.64% 0.00% Change
Estimated financial data (e)
Sales 2020 - - -
Net income 2020 -1,42 M -1,02 M -1,02 M
Net Debt 2020 2,50 M 1,79 M 1,79 M
P/E ratio 2020 -
Yield 2020 -
Sales 2021 - - -
Net income 2021 -3,90 M -2,80 M -2,80 M
Net cash position 2021 0,02 M 0,01 M 0,01 M
P/E ratio 2021 -7,08x
Yield 2021 -
Capitalization 34,6 M 24,7 M 24,8 M
EV / Sales 2020 -
EV / Sales 2021 -
Nbr of Employees -
Free-Float 0,87%
More Financials
Company
VGI Health Technology Limited, formerly Azure Health Technology Ltd, is an Australia-based biotechnology company. The Company's primary activities include researching, developing, distribution and marketing a range of health and therapeutic products and technologies, including drugs, wellbeing supplements and prescription medicines based on tocotrienols. Tocotrienols is a natural product, which has therapeutic... 
More about the company
All news about VGI HEALTH TECHNOLOGY LIMITED
01/24VGI HEALTH TECHNOLOGY : VTL contracts with Resonance Health for its NASH Phase II Clinical..
PU
01/24VGI HEALTH TECHNOLOGY LIMITED (NSX : VTL) Contract with Resonance Health (ASX:RHT)
AQ
01/19VGI HEALTH TECHNOLOGY LIMITED (NSX : VTL) Nutraceutical Products Listed on Amazon
AQ
01/19VGI HEALTH TECHNOLOGY : NE1-Elite® and NE1-Heart® nutraceutical products listed on Amazon
PU
01/18VGI HEALTH TECHNOLOGY LIMITED (NSX : VTL) Quarterly update
AQ
01/18VGI HEALTH TECHNOLOGY : Quarterly update for December '21 quarter
PU
2021VGI HEALTH TECHNOLOGY : PCT Patent Application for Transmucosal Delivery of Tocotrienols l..
PU
2021VGI HEALTH TECHNOLOGY LIMITED (NSX : VTL) Patent application lodged
AQ
2021VGI HEALTH TECHNOLOGY LIMITED (NSX : VTL) partners with ENDRA Life Sciences in NAFLD/NASH ..
AQ
2021VGI HEALTH TECHNOLOGY : partners with ENDRA Life Sciences in NAFLD/NASH Phase II Clinical ..
PU
2021VGI HEALTH TECHNOLOGY : VTL announces results of 2021 Annual General Meeting
PU
2021VGI Health Technology Limited Japanese Patent to be granted
AW
2021VGI HEALTH TECHNOLOGY LIMITED (NSX : VTL) Quarterly Update
AQ
2021VGI HEALTH TECHNOLOGY LIMITED (NSX : VTL) HREC Approval from RMH
AQ
2021VGI HEALTH TECHNOLOGY LIMITED (NSX : VTL) Draw Down of Convertible Note Facility
AQ
More news
News in other languages on VGI HEALTH TECHNOLOGY LIMITED

- No features available -

More news
Chart VGI HEALTH TECHNOLOGY LIMITED
Duration : Period :
VGI Health Technology Limited Technical Analysis Chart | VTL | AU0000152597 | MarketScreener
Income Statement Evolution
Managers and Directors
Glenn Tong CEO, Managing Director & Executive Director
Ian Forbes Chief Financial Officer
Louis James Panaccio Independent Non-Executive Chairman
David Kingston Chief Scientific Officer
Jiayi Yu Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
VGI HEALTH TECHNOLOGY LIMITED0.00%25
GILEAD SCIENCES, INC.-5.19%86 352
REGENERON PHARMACEUTICALS-4.49%63 067
VERTEX PHARMACEUTICALS3.42%57 743
WUXI APPTEC CO., LTD.-7.49%50 700
BIONTECH SE-39.30%37 796